12/06/2026
⚠️ Ebola Treatment: What We Have and What We Don't
As the WHO responds to the Bundibugyo virus outbreak, a critical reality must be understood: there is no approved vaccine or specific treatment for this strain.
What we DON'T have:
❌ FDA-approved vaccines for Bundibugyo (Ervebo and Zabdeno only work for Zaire strain)
❌ Specific antiviral medications for Bundibugyo
❌ Monoclonal antibody treatments (Inmazeb is Zaire-specific only)
What we DO have:
✓ Early, intensive supportive care
✓ Rehydration and electrolyte management
✓ Organ function support
✓ Symptomatic treatment (fever, pain management)
✓ Treatment of secondary infections
The critical fact: Survival depends on early, high-quality supportive care in designated Ebola Treatment Centers.
This is why:
◼ Early detection is essential
◼ Trained healthcare teams are vital
◼ Infection control prevents spread
◼ Intensive monitoring saves lives
In the absence of specific treatments, prevention and early supportive care are our strongest weapons.